Late-stage products are valuable, even ones with a somewhat troubled history. IntraBiotics Pharmaceuticals Inc.’s iseganan, in Phase III development, was enough to attract industry veteran Ernest Mario as its new CEO and chairman, a move accomplished by IntraBiotics acquiring Apothogen Inc., the company he founded. (BioWorld Today)

Late-stage products are valuable, even ones with a somewhat troubled history. IntraBiotics Pharmaceuticals Inc.’s iseganan, in Phase III development, was enough to attract industry veteran Ernest Mario as its new CEO and chairman, a move accomplished by IntraBiotics acquiring Apothogen Inc., the company he founded. (BioWorld Today)